1Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) [J]. JAMA, 2001,285 : 2486-2497.
2Haffner SM, Lehto S, Ronnemaa T, et al. Motality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[J]. N Engl J Med, 1998,339:229 234.
3Juutilainen A, Lehto S, Ronnemaa T, et al. Type 2 diabetes “ coronary heart disease equivalent”： an 18-year prospective population based study in Finnish subjects [J]. Diabetes Care, 2005,28:2901-2907.
4RazaJA, Movahed A. Current concepts of cardiovascular disease in diabetes mellitus [J] . Int J Cardiol, 2003, 89: 123- 134.
6Norhammar A, Malmberg K, Diderholm E. Diabetes mellitus: 50% hemolytic unit of complement major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization[J]. J Am Coil Cardiol, 2004, 43 : 585-591.
7Khaleeli E, Peters SR. Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease: Implications for management[J]. Am Heart J, 2001,141: 637-644.
8Bartnik M,Ryden L, Ferrari R. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart[J]. Eur Heart J, 2004,25:1861-1862.
9Bartnik M,Ryden L, Malmberg K . Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart[J]. Heart, 2007,93:72 77.
2King H,Aubert RE,Herman WH.Global burden of diabetes 1995-2025.Prevalence,numerical estimates and projections.Diabetes Care,1998,21:1414-1431.
3Bartnik M,Malmberg K,Hamsten A,et al.Abnormal glucose tolerance-a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.J Int Med,2004,256:288-297.
4Coutinho M,Gerstein HC,Wang Y,et al.The relationship between glucose and incident cardiovascular events:a metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4years.Diabetes Care,1999,22:233-240.
5The DECODE study group on behalf of the European Diabetes Epidemiology Group.Glucose tolerance and cardiovascular mortality.Arch Int Med,2001,161:397-404.
6Bartnik M,Malmberg K,Norhammar A,et al.Newly detected abnormal glucose tolerance:an important predictor of long-term outcome after myocardial infarction.Eur Heart J,2004,25:1990-1997.
7Norhammar A,Tenerz A,Nilsson G,et al.Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:a prospective study.Lancet,2002,359:2140-2144.
8Bartnik M,Ryden L,Ferrari R,et al.The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe:the Euro Heart Survey on diabetes and the heart.Eur Heart J,2004,25:1880-1890.
9Hashimoto K,Ikewaki K,Yagi H,et al.Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes.Diabetes Care,2005,28:1182-1186.
10Choi KM,Lee KW,Kim SG,et al.Inflammation,insulin resistance,and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus.J Clin Endocrinol Metab,2005,90:175 -180.
